{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:54:56Z","timestamp":1778619296872,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.thromres.2015.08.018","type":"journal-article","created":{"date-parts":[[2015,8,29]],"date-time":"2015-08-29T13:19:01Z","timestamp":1440854341000},"page":"870-877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy after drug-eluting stent implantation in coronary arteries: A meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"136","author":[{"given":"Yandun","family":"Zou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunling","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Likun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aidong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2015.08.018_bb0005","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.CIR.103.13.1718","article-title":"Inflammation and thrombosis: the clot thickens","volume":"103","author":"Libby","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2015.08.018_bb0010","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2015.08.018_bb0015","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1161\/CIRCULATIONAHA.104.530097","article-title":"Coronary stent restenosis in patients treated with cilostazol","volume":"112","author":"Douglas","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2015.08.018_bb0020","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.jacc.2010.07.028","article-title":"In-stent restenosis in the drug-eluting stent era","volume":"56","author":"Dangas","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2015.08.018_bb0025","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2015.08.018_bb0030","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"issue":"60","key":"10.1016\/j.thromres.2015.08.018_bb0035","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jacc.2012.06.004","volume":"2012","author":"Jneid","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"124","key":"10.1016\/j.thromres.2015.08.018_bb0040","first-page":"2574","volume":"2011","author":"Levine","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2015.08.018_bb0045","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jacc.2011.10.903","article-title":"Role of endothelial shear stress in stent restenosis and thrombosis: pathophysiologic mechanisms and implications for clinical translation","volume":"59","author":"Koskinas","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2015.08.018_bb0050","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0006-2952(94)90062-0","article-title":"Synergistic interactions between selective pharmacological inhibitors of phosphodiesterase isozyme families PDE III and PDE IV to attenuate proliferation of rat vascular smooth muscle cells","volume":"48","author":"Pan","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.thromres.2015.08.018_bb0055","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/01.HYP.0000158263.64320.eb","article-title":"Cilostazol inhibits vascular smooth muscle cell growth by downregulation of the transcription factor E2F","volume":"45","author":"Kim","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.thromres.2015.08.018_bb0060","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.5551\/jat.4309","article-title":"Inhibitory effects of cilostazol on proliferation of vascular smooth muscle cells (VSMCs) through suppression of the ERK1\/2 pathway","volume":"17","author":"Yoo","year":"2010","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.thromres.2015.08.018_bb0065","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(01)01742-9","article-title":"Coronary in-stent restenosis: current status and future strategies","volume":"39","author":"Lowe","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2015.08.018_bb0070","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1161\/01.ATV.0000037100.44766.5B","article-title":"Inflammation and restenosis in the stent era","volume":"22","author":"Welt","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2015.08.018_bb0075","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jacc.2010.08.631","volume":"57","author":"Suh","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2015.08.018_bb0080","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jacc.2010.10.035","volume":"57","author":"Lee","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2015.08.018_bb0085","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jacc.2007.11.049","volume":"51","author":"Lee","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2015.08.018_bb0090","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00380-010-0093-1","article-title":"Cilostazol reduces the progression of carotid intima\u2013media thickness without increasing the risk of bleeding in patients with acute coronary syndrome during a 2-year follow-up","volume":"26","author":"Ahn","year":"2011","journal-title":"Heart Vessel."},{"key":"10.1016\/j.thromres.2015.08.018_bb0095","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1016\/j.ijcard.2012.06.010","article-title":"Cilostazol added to aspirin and clopidogrel reduces revascularization without increases in major adverse events in patients with drug-eluting stents: a meta-analysis of randomized controlled trials","volume":"167","author":"Sakurai","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.thromres.2015.08.018_bb0100","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/0003319712474113","article-title":"Efficacy and safety of triple antiplatelet therapy in obese patients undergoing stent implantation","volume":"64","author":"Gao","year":"2013","journal-title":"Angiology"},{"key":"10.1016\/j.thromres.2015.08.018_bb0105","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ahj.2013.08.028","article-title":"Multicenter randomized trial of 3-month cilostazol use in addition to dual antiplatelet therapy after biolimus-eluting stent implantation for long or multivessel coronary artery disease","volume":"167","author":"Youn","year":"2014","journal-title":"Am. Heart J."},{"key":"10.1016\/j.thromres.2015.08.018_bb0110","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.thromres.2015.08.018_bb0115","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0."},{"key":"10.1016\/j.thromres.2015.08.018_bb0120","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1253\/circj.71.1685","article-title":"Effect of cilostazol on in-stent neointimal hyperplasia after coronary artery stenting: a quantative coronary angiography and volumetric intravascular ultrasound study","volume":"71","author":"Min","year":"2007","journal-title":"Circ. J."},{"key":"10.1016\/j.thromres.2015.08.018_bb0125","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa031859","article-title":"A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel","volume":"350","author":"Kastrati","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2015.08.018_bb0130","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2015.08.018_bb0135","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2015.08.018_bb0140","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.amjcard.2009.08.667","article-title":"Comparison of triple antiplatelet therapy and dual antiplatelet therapy in patients at high risk of restenosis after drug-eluting stent implantation (from the DECLARE-DIABETES and -LONG Trials)","volume":"105","author":"Lee","year":"2010","journal-title":"Am. J. Cardiol."},{"issue":"Suppl 2","key":"10.1016\/j.thromres.2015.08.018_bb0145","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1046\/j.1463-1326.2002.0040s2s14.x","article-title":"Pharmacology of cilostazol","volume":"4","author":"Schror","year":"2002","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.thromres.2015.08.018_bb0150","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2125.2011.04034.x","article-title":"Anti-platelet therapy: phosphodiesterase inhibitors","volume":"72","author":"Gresele","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.thromres.2015.08.018_bb0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.atherosclerosissup.2005.09.002","article-title":"Cilostazol: potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding","volume":"6","author":"Goto","year":"2005","journal-title":"Atheroscler. Suppl."},{"key":"10.1016\/j.thromres.2015.08.018_bb0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/07853890600643404","article-title":"Restenosis related to percutaneous coronary intervention has been solved?","volume":"38","author":"Kivela","year":"2006","journal-title":"Ann. Med."},{"key":"10.1016\/j.thromres.2015.08.018_bb0165","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1161\/CIRCULATIONAHA105.570093","article-title":"Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials","volume":"112","author":"Mauri","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2015.08.018_bb0170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.atherosclerosissup.2005.09.007","article-title":"A scientific rationale for the CREST trial results: evidence for the mechanism of action of cilostazol in restenosis","volume":"6","author":"Morishita","year":"2005","journal-title":"Atheroscler. Suppl."},{"key":"10.1016\/j.thromres.2015.08.018_bb0175","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1517\/14656566.2014.948844","article-title":"Pharmacological inhibition of coronary restenosis: systemic and local approaches","volume":"15","author":"Guerra","year":"2014","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.thromres.2015.08.018_bb0180","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.jacc.2004.06.066","article-title":"Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation","volume":"44","author":"Inoue","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2015.08.018_bb0185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.thromres.2010.10.021","article-title":"The cytochrome 2C19*2 and *3 alleles attenuate response to clopidogrel similarly in East Asian patients undergoing elective percutaneous coronary intervention","volume":"127","author":"Hwang","year":"2011","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2015.08.018_bb0190","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0009-9236(97)90088-6","article-title":"Direct evidence for the higher frequency of CYP2C19 allelic heterozygotes in Chinese subjects than in white subjects","volume":"62","author":"Xie","year":"1997","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.thromres.2015.08.018_bb0195","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.amjcard.2007.05.032","article-title":"Comparison of triple versus dual antiplatelet therapy after drug-eluting stent implantation (from the DECLARE-Long trial)","volume":"100","author":"Lee","year":"2007","journal-title":"Am. J. Cardiol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384815301006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384815301006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T22:28:01Z","timestamp":1537396081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384815301006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0049384815301006"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2015.08.018","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy after drug-eluting stent implantation in coronary arteries: A meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2015.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}